Jarosová M, Indrák K, Dusek J, Kapustová M
Department of Clinical Haematology, Faculty Hospital, Olomouc, Czechoslovakia.
Neoplasma. 1988;35(2):221-8.
A group of 54 patients with the original diagnosis of polycythemia vera were subjected to cytogenetic examination. Six (17.6%) of the 34 cases examined in the period of the advanced phase of the polycythemia vera had a chromosomal change. Thirteen (65%) of the 20 patients undergoing the cytogenetic examination in the period when the polycythemia vera turned into another myeloproliferative disease showed chromosomal aberration. This suggests a relationship between the number of chromosomal changes and the transformation of the disease. No connection between the cytogenetic changes and myelosuppressive cures could be confirmed in our material. The chromosomal change 20q- considered to be the most frequent kind in the polycythemia vera was not discovered until in patients with the polycythemia vera transformed into a different myeloproliferative disease.
对最初诊断为真性红细胞增多症的54例患者进行了细胞遗传学检查。在真性红细胞增多症晚期检查的34例患者中,有6例(17.6%)发生了染色体改变。在真性红细胞增多症转变为另一种骨髓增殖性疾病期间接受细胞遗传学检查的20例患者中,有13例(65%)出现了染色体畸变。这表明染色体改变的数量与疾病的转变之间存在关联。在我们的研究材料中,未证实细胞遗传学改变与骨髓抑制性治疗之间存在联系。被认为是真性红细胞增多症中最常见类型的染色体改变20q-,直到真性红细胞增多症转变为另一种骨髓增殖性疾病的患者中才被发现。